A Century of Cholesterol and Coronaries: From Plaques to Genes to Statins

Cited by (1,000)

Items 201–300 of 1,000

  1. Central nervous system cholesterol metabolism in health and disease
    Wan Yun Ho, Hannelore Hartmann, Shuo‐Chien Ling · 2022 · IUBMB Life
  2. Lipid accumulation and novel insight into vascular smooth muscle cells in atherosclerosis
    Yuxiao Liu, Pei-zhe Yuan, Jiehong Wu, Bo Hu · 2021 · Journal of Molecular Medicine
  3. Regulation of cellular cholesterol distribution via non-vesicular lipid transport at ER-Golgi contact sites
    Tomoki Naito, Haoning Yang, Dylan Hong Zheng Koh, Divyanshu Mahajan, Lei Lü, Yasunori Saheki · 2023 · Nature Communications
  4. The culprit is the carrier, not the loads: cholesterol, triglycerides and apolipoprotein B in atherosclerosis and coronary heart disease
    Mika Ala‐Korpela · 2019 · International Journal of Epidemiology
  5. Quantifying HDL proteins by mass spectrometry: how many proteins are there and what are their functions?
    Baohai Shao, Jay W. Heinecke · 2017 · Expert Review of Proteomics
  6. Modeling hypercholesterolemia and vascular lipid accumulation in LDL receptor mutant zebrafish
    Chao Liu, Young Sook Kim, Jungsu Kim, Jennifer Pattison, Andrés Kamaid, Yury I. Miller · 2018 · Journal of Lipid Research
  7. Maternal lipid profile and risk of pre-eclampsia in African pregnant women: A systematic review and meta-analysis
    Endalamaw Tesfa, Endalkachew Nibret, Abaineh Munshea · 2020 · PLoS ONE
  8. Organ cross-talk: molecular mechanisms, biological functions, and therapeutic interventions for diseases
    Huiting Che, Yidan Gao, Yonghu Xu, Hui Xu, Roland Eils, Mei Tian · 2026 · Signal Transduction and Targeted Therapy
  9. Structural basis of sterol binding and transport by a yeast StARkin domain
    Jentsch, Julian-Alexander, Kiburu, Irene, Pandey, Kalpana, Timme, Michael, Ramlall, Trudy, Levkau, Bodo, Wu, Jin, Eliezer, David, Boudker, Olga, Menon, Anant K. · 2018 · Journal of Biological Chemistry
  10. Maternal supraphysiological hypercholesterolemia associates with endothelial dysfunction of the placental microvasculature
    Bárbara Fuenzalida, Bastián Sobrevia, Claudette Cantin, Lorena Carvajal, Rocío Salsoso, Jaime Gutiérrez, Susana Contreras‐Duarte, Luis Sobrevía, Andrea Leiva · 2018 · Scientific Reports
  11. Cholesterol Serum Levels and Use of Statins in Graves' Orbitopathy: A New Starting Point for the Therapy
    Giulia Lanzolla, Guia Maria Vannucchi, Ilaria Ionni, Irene Campi, Federica Sileo, Elisa Lazzaroni, Michele Marinò · 2020 · Frontiers in Endocrinology
  12. Cholesterol – the devil you know; ceramide – the devil you don’t
    Trevor S. Tippetts, William L. Holland, Scott A. Summers · 2021 · Trends in Pharmacological Sciences
  13. Current Understanding on the Role of Lipids in Macrophages and Associated Diseases
    Ida Florance, Ramasubbu Seenivasan · 2022 · International Journal of Molecular Sciences
  14. Dual mechanisms of cholesterol-GPCR interactions that depend on membrane phospholipid composition
    Arka Prabha Ray, Naveen Thakur, Niloofar Gopal Pour, Matthew T. Eddy · 2023 · Structure
  15. Underlying mechanisms for sterol-induced ubiquitination and ER-associated degradation of HMG CoA reductase
    Brittany M. Johnson, Russell A. DeBose‐Boyd · 2018 · Seminars in Cell and Developmental Biology
  16. SREBP1-dependent de novo fatty acid synthesis gene expression is elevated in malignant melanoma and represents a cellular survival trait
    Su Wu, Anders M. Näär · 2019 · Scientific Reports
  17. EGF‐like and Other Disulfide‐rich Microdomains as Therapeutic Scaffolds
    Benjamin J. Tombling, Conan K. L. Wang, David J. Craik · 2019 · Angewandte Chemie International Edition
  18. Polygonatum sibiricum polysaccharides protect against obesity and non-alcoholic fatty liver disease in rats fed a high-fat diet
    Li Zeng, Fang-Wei Zhong, Zhi-Liang Chen, Geng-Xi Li, Qi Zhu · 2022 · Food Science and Human Wellness
  19. Contribution of Accelerated Degradation to Feedback Regulation of 3-Hydroxy-3-methylglutaryl Coenzyme A Reductase and Cholesterol Metabolism in the Liver
    Seonghwan Hwang, Isamu Z. Hartman, Leona N. Calhoun, Kristina Garland, Gennipher A. Young, Matthew A. Mitsche, Jeffrey G. McDonald, Fang Xu, Luke J. Engelking, Russell A. DeBose‐Boyd · 2016 · Journal of Biological Chemistry
  20. Membrane cholesterol mediates the cellular effects of monolayer graphene substrates
    Kristina E. Kitko, Tu Hong, Roman M. Lazarenko, Da Ying, Ya‐Qiong Xu, Qi Zhang · 2018 · Nature Communications
  21. Endogenous cholesterol ester hydroperoxides modulate cholesterol levels and inhibit cholesterol uptake in hepatocytes and macrophages
    Shuyuan Guo, Jianhong Lu, Yujuan Zhuo, Mengqing Xiao, Xinli Xue, Shanshan Zhong, Xia Shen, Chunzhao Yin, Luxiao Li, Qun Chen et al. · 2018 · Redox Biology
  22. Cideb controls sterol‐regulated ER export of SREBP/SCAP by promoting cargo loading at ER exit sites
    Lü Su, Linkang Zhou, Feng‐Jung Chen, Huimin Wang, Hui Qian, Yuanyuan Sheng, Yuangang Zhu, Hua Jian Yu, Xinqi Gong, Li'e Cai et al. · 2019 · The EMBO Journal
  23. Statin-Induced Chronic Cholesterol Depletion Switches GPCR Endocytosis and Trafficking: Insights from the Serotonin1A Receptor
    G. Aditya Kumar, Amitabha Chattopadhyay · 2019 · ACS Chemical Neuroscience
  24. White tea and its active polyphenols lower cholesterol through reduction of very-low-density lipoprotein production and induction of LDLR expression
    Kun Luo, Chengmei Ma, Shaofang Xing, Yan-Nan An, Juan Feng, Honglei Dang, Wenting Huang, Liansheng Qiao, Jing Cheng, Lan Xie · 2020 · Biomedicine & Pharmacotherapy
  25. Anti-tumor effects of mevalonate pathway inhibition in ovarian cancer
    Andy Göbel, Valentina M. Zinna, S. Dell'Endice, Nikolai Jaschke, Jan Dominik Kuhlmann, Pauline Wimberger, Tilman D. Rachner · 2020 · BMC Cancer
  26. Targeting cholesterol homeostasis in hematopoietic malignancies
    Andrea Brendolan, Vincenzo E. A. Russo · 2021 · Blood
  27. The administration of drugs inhibiting cholesterol/oxysterol synthesis is safe and increases the efficacy of immunotherapeutic regimens in tumor-bearing mice
    Claudia Lanterna, Andrea Musumeci, Laura Raccosta, Gianfranca Corna, Marta Angiola Moresco, Daniela Maggioni, Raffaella Fontana, Claudio Doglioni, Claudio Bordignon, Catia Traversari et al. · 2016 · Cancer Immunology Immunotherapy
  28. atherosclerosis: gone with the Wnt?
    Philippe Boucher, Rachel L. Matz, Jérôme Terrand · 2020 · Atherosclerosis
  29. Overview: Lipid Metabolism in the Tumor Microenvironment
    Kaili Ma, Lianjun Zhang · 2021 · Advances in experimental medicine and biology
  30. Dyslipidemia and Its Role in the Pathogenesis of Atherosclerotic Cardiovascular Disease: Implications for Evaluation and Targets for Treatment of Dyslipidemia Based on Recent Guidelines
    Perry Wengrofsky, Justin Lee, Amgad N. Makaryus · 2019 · IntechOpen eBooks
  31. Lipid-based biomarkers for CVD, COPD, and aging – A translational perspective
    Kim Ekroos, Oksana Lavrynenko, Bjoern Titz, Calin Pater, Julia Hoeng, Nikolai V. Ivanov · 2020 · Progress in Lipid Research
  32. Clinical characterization and mutation spectrum of German patients with familial hypercholesterolemia
    Thomas Grenkowitz, Ursula Kassner, Marion Wühle-Demuth, Bastian Salewsky, Adrian Rosada, Tomasz Żemojtel, Werner Hopfenmüller, Berend Isermann, Katrin Borucki, Franz Heigl et al. · 2016 · Atherosclerosis
  33. Proprotein convertase subtilisin/kexin type 9 and lipid metabolism
    Stefano Spolitu, Wen Dai, John A. Zadroga, Lale Özcan · 2019 · Current Opinion in Lipidology
  34. Data storytelling is not storytelling with data: A framework for storytelling in science communication and data journalism
    Matei, Sorin Adam, Hunter, Lucas · 2021 · The Information Society
  35. Hydroxylation site–specific and production-dependent effects of endogenous oxysterols on cholesterol homeostasis: Implications for SREBP-2 and LXR
    Hodaka Saito, Wakana Tachiura, Mizuki Nishimura, Makoto Shimizu, Ryuichiro Sato, Yoshio Yamauchi · 2022 · Journal of Biological Chemistry
  36. Theoretical framework and emerging challenges of lipid metabolism in cancer
    Qiuying Gu, Yuan Wang, Ping Yi, Chunming Cheng · 2024 · Seminars in Cancer Biology
  37. The Liver Clock Controls Cholesterol Homeostasis through Trib1 Protein-mediated Regulation of PCSK9/Low Density Lipoprotein Receptor (LDLR) Axis
    Di Ma, Tongyu Liu, Lin Chang, Crystal Rui, Yuanyuan Xiao, Siming Li, John B. Hogenesch, Y. Eugene Chen, Jiandie D. Lin · 2015 · Journal of Biological Chemistry
  38. Research into cancer metabolomics: Towards a clinical metamorphosis
    Orianne Olivares, J. Henry M. Däbritz, Ayala King, Eyal Gottlieb, Christina Halsey · 2015 · Seminars in Cell and Developmental Biology
  39. A Diet-Sensitive BAF60a-Mediated Pathway Links Hepatic Bile Acid Metabolism to Cholesterol Absorption and Atherosclerosis
    Zhuo‐Xian Meng, Lin Wang, Lin Chang, Jingxia Sun, Jiangyin Bao, Yaqiang Li, Y. Eugene Chen, Jiandie D. Lin · 2015 · Cell Reports
  40. The early years of lipoprotein research: from discovery to clinical application
    Patty W. Siri‐Tarino, Ronald M. Krauss · 2016 · Journal of Lipid Research
  41. Microbial Reduction of Cholesterol to Coprostanol: An Old Concept and New Insights
    Aïcha Kriaa, Mélanie Bourgin, Héla Mkaouar, Amin Jablaoui, Nizar Akermi, Souha Soussou, Emmanuelle Maguin, Moez Rhimi · 2019 · Catalysts
  42. Ginsenoside Rg3 Alleviates ox-LDL Induced Endothelial Dysfunction and Prevents Atherosclerosis in ApoE−/− Mice by Regulating PPARγ/FAK Signaling Pathway
    Jianan Geng, Wenwen Fu, Xiaofeng Yu, Zeyuan Lu, Yanzhe Liu, Mingyang Sun, Ping Yu, Xin Li, Li Fu, Huali Xu et al. · 2020 · Frontiers in Pharmacology
  43. The biology of atherosclerosis comes full circle: lessons for conquering cardiovascular disease
    Peter Libby · 2021 · Nature Reviews Cardiology
  44. Genetic testing for familial hypercholesterolemia: Impact on diagnosis, treatment and cardiovascular risk
    Seohyuk Lee, Leo E. Akioyamen, Sumayah Aljenedil, Jean‐Baptiste Rivière, Isabelle L. Ruel, Jacques J. Genest · 2019 · European Journal of Preventive Cardiology
  45. Drug treatment of chronic subdural hematoma
    Jinhao Huang, Chuang Gao, Jing‐fei Dong, Jianning Zhang, Rongcai Jiang · 2020 · Expert Opinion on Pharmacotherapy
  46. Low-dose pollutant mixture triggers metabolic disturbances in female mice leading to common and specific features as compared to a high-fat diet
    Emmanuel Labaronne, Claudie Pinteur, Nathalie Véga, Sandra Pesenti, Benoit Julien, Emmanuelle Meugnier, Hubert Vidal, Danielle Naville, Brigitte Le Magueresse‐Battistoni · 2017 · The Journal of Nutritional Biochemistry
  47. Organelle Communication at Membrane Contact Sites (MCS): From Curiosity to Center Stage in Cell Biology and Biomedical Research
    Thomas Simmen, Mitsuo Tagaya · 2017 · Advances in experimental medicine and biology
  48. Simvastatin inhibits sonic hedgehog signaling and stemness features of pancreatic cancer
    Yefeng Yin, Li Liu, Zhefu Zhao, Libo Yin, Nathalie Bauer, Clifford C. Nwaeburu, Jury Gladkich, Wolfgang Groß, Thilo Hackert, Carsten Sticht et al. · 2018 · Cancer Letters
  49. Effects of statin exposure and lung cancer survival: A meta-analysis of observational studies
    Yafei Chen, Xiaoli Li, Rui Zhang, Yuhong Xia, Zhuo Shao, Zubing Mei · 2019 · Pharmacological Research
  50. Vesicular and non-vesicular lipid export from the ER to the secretory pathway
    Kouichi Funato, Howard Riezman, Manuel Muñiz · 2019 · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids
  51. A point mutation decouples the lipid transfer activities of microsomal triglyceride transfer protein
    Meredith H. Wilson, Sujith Rajan, Aidan Danoff, Richard Joseph White, Monica R. Hensley, Vanessa H. Quinlivan, Rosario Recacha, James H. Thierer, Frederick J. Tan, Elisabeth M. Busch‐Nentwich et al. · 2020 · PLoS Genetics
  52. N6-methyladenosine modification and metabolic reprogramming of digestive system malignancies
    Xianlei Cai, Chao Liang, Miaozun Zhang, Yuan Xu, Yihui Weng, Xueying Li, Weiming Yu · 2022 · Cancer Letters
  53. LDL-C: The Only Causal Risk Factor for ASCVD. Why Is It Still Overlooked and Underestimated?
    Lamija Ferhatbegović, Denis Mršić, Sabina Kušljugić, Belma Pojskić · 2022 · Current Atherosclerosis Reports
  54. Manganese regulation of COPII condensation controls circulating lipid homeostasis
    Xiao Wang, Runze Huang, Yawei Wang, Wenjing Zhou, Yating Hu, Yuanhang Yao, Kunlun Cheng, Xin Li, Bolin Xu, Jie Zhang et al. · 2023 · Nature Cell Biology
  55. Combination statin and chemotherapy inhibits proliferation and cytotoxicity of an aggressive natural killer cell leukemia
    Austin Bryce Henslee, Timothy A. Steele · 2018 · Biomarker Research
  56. Lysosome function in glomerular health and disease
    Catherine Meyer‐Schwesinger · 2021 · Cell and Tissue Research
  57. GRAMD1-mediated accessible cholesterol sensing and transport
    Tomoki Naito, Yasunori Saheki · 2021 · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids
  58. Keep recycling going: new approaches to reduce LDL-C
    Klein-Szanto, Andres J.P., Bassi, Daniel E. · 2019 · Biochemical Pharmacology
  59. Low-density Lipoprotein-Cholesterol Lowering Strategies for Prevention of Atherosclerotic Cardiovascular Disease: Focus on siRNA Treatment Targeting PCSK9 (Inclisiran)
    Sinning, David, Landmesser, Ulf · 2020 · Current Cardiology Reports
  60. Cholesterol crystals and atherosclerotic plaque instability: Therapeutic potential of Eicosapentaenoic acid
    M. John Chapman, Richard Preston Mason · 2022 · Pharmacology & Therapeutics
  61. Macrophage polarisation and inflammatory mechanisms in atherosclerosis: Implications for prevention and treatment
    Bo Yang, Sanhua Hang, Siting Xu, Yun Gao, Wenhua Yu, Guangyao Zang, Lili Zhang, Zhongqun Wang · 2024 · Heliyon
  62. Cholesterol induces lipoprotein lipase expression in a tree shrew (Tupaia belangeri chinensis) model of non-alcoholic fatty liver disease
    Linqiang Zhang, Zhiguo Zhang, Yunhai Li, Shasha Liao, Xiaoyun Wu, Qing Chang, Bin Liang · 2015 · Scientific Reports
  63. Biofabricating atherosclerotic plaques: In vitro engineering of a three-dimensional human fibroatheroma model
    Anna Mallone, Chantal Stenger, Arnold von Eckardstein, Simon Philipp Hoerstrup, Benedikt Weber · 2017 · Biomaterials
  64. ANGPTL3 Inhibitors ― Their Role in Cardiovascular Disease Through Regulation of Lipid Metabolism ―
    Eleni V. Geladari, Panagiota Tsamadia, Natalia G. Vallianou · 2018 · Circulation Journal
  65. Coordinate Regulation of Cholesterol and Bile Acid Metabolism by the Clock Modifier Nobiletin in Metabolically Challenged Old Mice
    Kazunari Nohara, Travis G. Nemkov, Angelo D’Alessandro, Seung Hee Yoo, Zheng Chen · 2019 · International Journal of Molecular Sciences
  66. Colesterol LDL y aterosclerosis: evidencias
    Carlos Guijarro, Juan Cosı́n-Sales · 2021 · Clínica e Investigación en Arteriosclerosis
  67. Visualization of accessible cholesterol using a GRAM domain-based biosensor
    Dylan Hong Zheng Koh, Tomoki Naito, Minyoung Na, Yee Jie Yeap, Pritisha Rozario, Franklin L. Zhong, Kah‐Leong Lim, Yasunori Saheki · 2023 · Nature Communications
  68. Genetically engineered livestock for biomedical models
    Christopher S. Rogers · 2016 · Transgenic Research
  69. Cardiovascular disease in patients with genotyped familial hypercholesterolemia in Norway during 1994–2009, a registry study
    Liv J. Mundal, Marit Bragelien Veierød, Thomas Halvorsen, Kirsten Bjørklund Holven, Leiv Ose, Per Ole Iversen, Grethe Seppola Tell, Trond P. Leren, Kjetil Retterstøl · 2016 · European Journal of Preventive Cardiology
  70. Muscle and statins: from toxicity to the nocebo effect
    Juan Pedro‐Botet, Elisenda Climent, David Benaiges · 2019 · Expert Opinion on Drug Safety
  71. Different mechanisms for selective transport of fatty acids using a single class of lipoprotein in Drosophila
    Naoya Matsuo, Kohjiro Nagao, Takuto Suito, Naoto Juni, Utako Kato, Yuji Hara, Masato Umeda · 2019 · Journal of Lipid Research
  72. Structural and Functional Specialization of OSBP-Related Proteins
    V. Delfosse, William Bourguet, Guillaume Drin · 2020 · Contact
  73. Insensitivity to atorvastatin is associated with increased accumulation of intracellular lipid droplets and fatty acid metabolism in breast cancer cells
    Barbara Lettiero, Maria Inasu, Siker Kimbung, Signe Borgquist · 2018 · Scientific Reports
  74. The improvements of functional ingredients from marine foods in lipid metabolism
    Teng Wang, Changhu Xue, Tiantian Zhang, Yuming Wang · 2018 · Trends in Food Science & Technology
  75. Development of Novel DNA-Encoded PCSK9 Monoclonal Antibodies as Lipid-Lowering Therapeutics
    Makan Khoshnejad, Ami R. Patel, Krzysztof Wojtak, Sagar B. Kudchodkar, Laurent M. P. F. Humeau, Nicholas N. Lyssenko, Daniel James Rader, Kar Muthumani, David B. Weiner · 2018 · Molecular Therapy
  76. Unripe Rubus coreanus Miquel Extract Containing Ellagic Acid Regulates AMPK, SREBP-2, HMGCR, and INSIG-1 Signaling and Cholesterol Metabolism In Vitro and In Vivo
    Ki Hoon Lee, Eui-seon Jeong, Goeun Jang, Ju-Ryun Na, Soyi Park, Wan Seok Kang, Eun Sun Kim, Hakjoon Choi, Jin Seok Kim, Sunoh Kim · 2020 · Nutrients
  77. Insights into incretin-based therapies for treatment of diabetic dyslipidemia
    Kerstin Stemmer, Brian Finan, Richard D. DiMarchi, Matthias H. Tschöp, Timo D. Müller · 2020 · Advanced Drug Delivery Reviews
  78. Membrane cholesterol regulates endocytosis and trafficking of the serotonin1A receptor: Insights from acute cholesterol depletion
    G. Aditya Kumar, Amitabha Chattopadhyay · 2021 · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids
  79. Hyaluronan in pathophysiology of vascular diseases: specific roles in smooth muscle cells, endothelial cells, and macrophages
    Arianna Parnigoni, Manuela Viola, Evgenia G. Karousou, Simona Rovera, Cristina Giaroni, Alberto G. Passi, Davide Vigetti · 2022 · American Journal of Physiology-Cell Physiology
  80. Crystal structure of a mycobacterial Insig homolog provides insight into how these sensors monitor sterol levels
    Ruobing Ren, Xinhui Zhou, Yuan He, Meng Ke, Jianping Wu, Xiaohui Liu, Chuangye Yan, Yixuan Wu, Xin Gong, Xiaoguang Lei et al. · 2015 · Science
  81. Degradation and beyond
    Ismail Sergin, Trent D. Evans, Babak Razani · 2015 · Current Opinion in Lipidology
  82. New precision medicine avenues to the prevention of Alzheimer’s disease from insights into the structure and function of γ-secretases
    De Strooper, Bart, Karran, Eric · 2024 · The EMBO Journal
  83. Statin therapy inhibits fatty acid synthase via dynamic protein modifications
    Alec G. Trub, Gregory R. Wagner, Kristin A. Anderson, Scott B. Crown, Guofang Zhang, J. Will Thompson, Olga Ilkayeva, Robert David Stevens, Paul A. Grimsrud, Rhushikesh A. Kulkarni et al. · 2022 · Nature Communications
  84. A concerted mechanism involving ACAT and SREBPs by which oxysterols deplete accessible cholesterol to restrict microbial infection
    David B. Heisler, Kristen A. Johnson, Maikke B. Ohlson, Duo H Ma, Lishu Zhang, Michelle Tran, Chase D. Corley, Michael E. Abrams, Jeffrey G. McDonald, John W. Schoggins et al. · 2023 · eLife
  85. Proprotein convertase subtilisn/kexin type 9 inhibitors and small interfering RNA therapy for cardiovascular risk reduction: A systematic review and meta-analysis
    Tasnim F. Imran, Ali Aamir Khan, Phinnara Has, Alexis Jacobson, Stephanie Bogin, Mahnoor Khalid, Asim Ali Khan, Samuel Kim, Sebhat A. Erqou, Gaurav Choudhary et al. · 2023 · PLoS ONE
  86. Dual Targeting of 3-Hydroxy-3-methylglutaryl Coenzyme A Reductase and Histone Deacetylase as a Therapy for Colorectal Cancer
    Tzu-Tang Wei, Yi‐Ting Lin, Wenshu Chen, Ping Luo, Yu‐Chin Lin, Chia‐Tung Shun, Yi-Hsin Lin, Jhih-Bin Chen, Nai-Wei Chen, Jim‐Min Fang et al. · 2016 · EBioMedicine
  87. Proteostatic Tactics in the Strategy of Sterol Regulation
    Margaret A. Wangeline, Nidhi Vashistha, Randolph Y. Hampton · 2017 · Annual Review of Cell and Developmental Biology
  88. Hepatocyte ABCA1 Deletion Impairs Liver Insulin Signaling and Lipogenesis
    Chia-Chi C. Key, Mingxia Liu, C. Lisa Kurtz, Soonkyu Chung, Elena Y. Boudyguina, Timothy A. Dinh, Alexander C. Bashore, Peter E. Phelan, Barry I. Freedman, Timothy F. Osborne et al. · 2017 · Cell Reports
  89. Therapeutic FGF19 promotes HDL biogenesis and transhepatic cholesterol efflux to prevent atherosclerosis
    Mei Zhou, R. Marc Learned, Stephen J. Rossi, Hui Tian, Alex M. DePaoli, Lei Ling · 2019 · Journal of Lipid Research
  90. The effect of genetic variation in PCSK9 on the LDL-cholesterol response to statin therapy
    QiPing Feng, Wei-Qi Wei, Cecilia P. Chung, Rebecca T. Levinson, Lisa A. Bastarache, Joshua C. Denny, C. Michael Stein · 2016 · The Pharmacogenomics Journal
  91. Defective AMPK regulation of cholesterol metabolism accelerates atherosclerosis by promoting HSPC mobilization and myelopoiesis
    Man K.S. Lee, Olivia D. Cooney, Xuzhu Lin, Shaktypreya Nadarajah, Dragana Dragoljevic, Kevin Huynh, Danise-Ann Onda, Sandra Galić, Peter J. Meikle, Helena Edlund et al. · 2022 · Molecular Metabolism
  92. Natural Product-Inspired Targeted Protein Degraders: Advances and Perspectives
    Jiao Li, Zhenyu Cai, Xu‐Wen Li, Chunlin Zhuang · 2022 · Journal of Medicinal Chemistry
  93. CSN6‐SPOP‐HMGCS1 Axis Promotes Hepatocellular Carcinoma Progression via YAP1 Activation
    Kai Li, Jiayu Zhang, Haiwen Lyu, Jinneng Yang, Wenxia Wei, Yuzhi Wang, Haidan Luo, Yijing Zhang, Xin Jian Jiang, Hairong Yi et al. · 2024 · Advanced Science
  94. Statin action enriches HDL3 in polyunsaturated phospholipids and plasmalogens and reduces LDL-derived phospholipid hydroperoxides in atherogenic mixed dyslipidemia
    Alexina Orsoni, Patrice Thérond, Ricardo Tan, Philippe Giral, Paul Robillard, Anatol Kontush, Peter J. Meikle, M. John Chapman · 2016 · Journal of Lipid Research
  95. Zinc mediates the SREBP-SCD axis to regulate lipid metabolism in Caenorhabditis elegans
    Jingjing Zhang, Junjun Hao, Yuru Zhang, Yanli Wang, Mingyi Li, Huilai Miao, Xiao-Ju Zou, Bin Liang · 2017 · Journal of Lipid Research
  96. Chasing LDL cholesterol to the bottom — PCSK9 in perspective
    Peter Libby, Lale S Tokgözoğlu · 2022 · Nature Cardiovascular Research
  97. Complex structure of the fission yeast SREBP-SCAP binding domains reveals an oligomeric organization
    Gong, Xin, Qian, Hongwu, Shao, Wei, Li, Jingxian, Wu, Jianping, Liu, Jun-Jie, Li, Wenqi, Wang, Hong-Wei, Espenshade, Peter, Yan, Nieng · 2016 · Cell Research
  98. β-Cell–Specific Deletion of HMG-CoA (3-hydroxy-3-methylglutaryl-coenzyme A) Reductase Causes Overt Diabetes due to Reduction of β-Cell Mass and Impaired Insulin Secretion
    Shoko Takei, Shuichi Nagashima, Akihito Takei, Daisuke Yamamuro, Tetsuji Wakabayashi, Akiko Murakami, Masayo Isoda, Hisataka Yamazaki, Chihiro Ebihara, Manabu Takahashi et al. · 2020 · Diabetes
  99. Functional Peroxisomes Are Essential for Efficient Cholesterol Sensing and Synthesis
    Charles, Khanichi N., Shackelford, Janis E., Faust, Phyllis L., Fliesler, Steven J., Stangl, Herbert, Kovacs, Werner J. · 2020 · Frontiers in Cell and Developmental Biology
  100. The Targeting of Native Proteins to the Endoplasmic Reticulum-Associated Degradation (ERAD) Pathway: An Expanding Repertoire of Regulated Substrates
    Deepa Kumari, Jeffrey L. Brodsky · 2021 · Biomolecules